Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy

Acute myeloid leukemia (AML) is an aggressive malignancy, and many elderly/unfit patients cannot receive intensive and potentially curative therapy. These patients receive low-toxicity disease-stabilizing treatment. The combination of all-trans retinoic acid (ATRA) and the histone deacetylase inhibi...

全面介紹

書目詳細資料

Principais autores:	Ida Sofie Grønningsæter, Hanne Kristin Fredly, Bjørn Tore Gjertsen, Kimberley Joanne Hatfield, Øystein Bruserud
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2019-10-01
叢編:	Cells
主題:	acute myeloid leukemia all-trans retinoic acid lipids metabolomics valproic acid
在線閱讀:	https://www.mdpi.com/2073-4409/8/10/1229
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!